[go: up one dir, main page]

DD276280A5 - Verwendung von 2,6-diamino-3-halogeno-benzyl-pyridinen zur herstellung eines arzneimittels - Google Patents

Verwendung von 2,6-diamino-3-halogeno-benzyl-pyridinen zur herstellung eines arzneimittels Download PDF

Info

Publication number
DD276280A5
DD276280A5 DD87323143A DD32314387A DD276280A5 DD 276280 A5 DD276280 A5 DD 276280A5 DD 87323143 A DD87323143 A DD 87323143A DD 32314387 A DD32314387 A DD 32314387A DD 276280 A5 DD276280 A5 DD 276280A5
Authority
DD
German Democratic Republic
Prior art keywords
diamino
medicament
formula
pyridines
benzyl
Prior art date
Application number
DD87323143A
Other languages
German (de)
English (en)
Inventor
Peter Emig
Juergen Engel
Gerhard Scheffler
Carl H Weischer
Bernd Nickel
Original Assignee
��@���������@�������k��
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ��@���������@�������k�� filed Critical ��@���������@�������k��
Publication of DD276280A5 publication Critical patent/DD276280A5/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/73Unsubstituted amino or imino radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pain & Pain Management (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DD87323143A 1986-11-06 1987-11-04 Verwendung von 2,6-diamino-3-halogeno-benzyl-pyridinen zur herstellung eines arzneimittels DD276280A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19863637829 DE3637829A1 (de) 1986-11-06 1986-11-06 Neue 2,6-diamino-3-halogenobenzylpyridine und verfahren zu ihrer herstellung sowie ihre verwendung in pharmazeutika

Publications (1)

Publication Number Publication Date
DD276280A5 true DD276280A5 (de) 1990-02-21

Family

ID=6313302

Family Applications (2)

Application Number Title Priority Date Filing Date
DD87323143A DD276280A5 (de) 1986-11-06 1987-11-04 Verwendung von 2,6-diamino-3-halogeno-benzyl-pyridinen zur herstellung eines arzneimittels
DD87308667A DD270903A5 (de) 1986-11-06 1987-11-04 Verfahren zur herstellung neuer 2,6-diamino-3-halogene-benzylpyridine

Family Applications After (1)

Application Number Title Priority Date Filing Date
DD87308667A DD270903A5 (de) 1986-11-06 1987-11-04 Verfahren zur herstellung neuer 2,6-diamino-3-halogene-benzylpyridine

Country Status (16)

Country Link
US (1) US4851420A (fi)
EP (1) EP0266711A1 (fi)
JP (1) JPS63132875A (fi)
KR (1) KR880006198A (fi)
CN (1) CN87106966A (fi)
AU (1) AU596708B2 (fi)
DD (2) DD276280A5 (fi)
DE (1) DE3637829A1 (fi)
DK (1) DK581487A (fi)
FI (1) FI874875A7 (fi)
HU (1) HU197882B (fi)
IL (1) IL84366A0 (fi)
NO (1) NO874617L (fi)
PL (1) PL149462B1 (fi)
PT (1) PT86085B (fi)
ZA (1) ZA878324B (fi)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6943034B1 (en) * 1991-11-22 2005-09-13 Affymetrix, Inc. Combinatorial strategies for polymer synthesis
CN102285887A (zh) * 2011-06-28 2011-12-21 中国科学技术大学 一种制备硝基取代的二苯甲烷及其衍生物的方法
BR112020014146A2 (pt) * 2018-02-05 2020-12-08 Université De Strasbourg Compostos e composições para o tratamento da dor
AU2020324546A1 (en) 2019-08-06 2022-03-10 Domain Therapeutics 5-heteroaryl-pyridin-2-amine confounds as neuropeptide ff receptor antagonists

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3954782A (en) * 1972-06-22 1976-05-04 Cassella Farbwerke Mainkur Aktiengesellschaft 2,6-Hydrazino-3-pyridine carboxyamides
FI750998A7 (fi) * 1974-04-12 1975-10-13 Sandoz Ag

Also Published As

Publication number Publication date
FI874875A0 (fi) 1987-11-04
US4851420A (en) 1989-07-25
PT86085A (de) 1987-12-01
NO874617D0 (no) 1987-11-05
DK581487A (da) 1988-05-07
NO874617L (no) 1988-05-09
CN87106966A (zh) 1988-08-31
IL84366A0 (en) 1988-04-29
DD270903A5 (de) 1989-08-16
DK581487D0 (da) 1987-11-05
KR880006198A (ko) 1988-07-22
PL268592A1 (en) 1988-10-13
JPS63132875A (ja) 1988-06-04
PL149462B1 (en) 1990-02-28
HUT45502A (en) 1988-07-28
AU596708B2 (en) 1990-05-10
HU197882B (en) 1989-06-28
ZA878324B (en) 1988-05-03
DE3637829A1 (de) 1988-05-11
FI874875L (fi) 1988-05-07
EP0266711A1 (de) 1988-05-11
FI874875A7 (fi) 1988-05-07
AU8082687A (en) 1988-05-12
PT86085B (pt) 1990-11-20

Similar Documents

Publication Publication Date Title
CH635823A5 (de) Verfahren zur herstellung von neuen 1-amidin-3-substituierten-phenylharnstoffen.
DD141520A5 (de) Verfahren zur herstellung neuer derivate von 4-amino-5-alkylsulfonyl-ortho-anisamiden
DE2455353C3 (de) Substituierte a -Aminooxvcarbonsäurehydrazidderivate und ihre Säureadditionssalze sowie ihre Verwendung vnd Verfahren zur Herstellung derselben
DE2461802C2 (de) Pyrazincarboxamidderivate
DE3442860A1 (de) 5-alkyl-1-phenyl-2-piperazinoalkylpyrazolin-3- on-verbindungen sowie verfahren und zwischenprodukte zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
EP0557879A1 (de) 4-Amino-2-ureido-pyrimidin-5-carbonsäureamide, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung
DE2523103A1 (de) Neue propargyl-2-phenylamino-imidazoline-(2), deren saeureadditionssalze, diese enthaltende arzneimittel und verfahren zur herstellung derselben
DE2800316A1 (de) Oximether enthaltende arzneimittel zur bekaempfung von ulcera, oximether und verfahren zu ihrer herstellung
DE2720545A1 (de) Neue chinazolinderivate, ihre herstellung und pharmazeutische mittel
EP0072960B1 (de) 1,5-Diphenylpyrazolin-3-on-Verbindungen sowie Verfahren und Zwischenprodukte zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE2247186A1 (de) Antimykotisches mittel
DE2242454A1 (de) 1-aethyl-imidazole, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DD276280A5 (de) Verwendung von 2,6-diamino-3-halogeno-benzyl-pyridinen zur herstellung eines arzneimittels
DE2757532A1 (de) N,n'-disubstituiertes cyclisches diamin und verfahren zu dessen herstellung
EP0224159B1 (de) Neue basisch substituierte Pyridinverbindungen, Verfahren zu ihrer Herstellung, die sie enthaltenden Arzneimittel und ihre Verwendung
DE2440734C2 (de) Amphetaminderivate, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
DE2259471C2 (de) 2-Halogen-9-phenyl-5,6-dihydro-7H-pyrido [2,3-f] [1,4] diazepinderivate
EP0026321A1 (de) 6-Imidazol-1-yl-3-hydrazino-pyridazine, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
EP0073931B1 (de) Neue Anilino-1,2,3-triazol-Derivate, diese enthaltende Arzneimittel sowie Verfahren zu deren Herstellung und deren Verwendung
DE2137538A1 (de) Methoxyaminderivate und ihre Salze sowie ihre Verwendimg und Verfahren zur Herstellung derselben
DE2609574A1 (de) Monosubstituiertes piperazinderivat, verfahren zu seiner herstellung und es enthaltende arzneimittel
DE2029991C3 (de) 2-Hydroxy-5-aminobenzamide, Verfahren zu ihrer Herstellung und Arzneimittel, die diese Verbindungen enthalten
DE2856722A1 (de) Acylhydrocarbylaminoalkansaeuren, ihre herstellung und verwendung sowie sie enthaltende arzneimittel
DE2242375C3 (de) 1,4-Disubstituierte 6-Nitro-2(1 H(-chinazolinone
EP0557877A1 (de) Lösliche Salze von 4-Amino-2-(4,4-dimethyl-imidazolidin-2-on-1-yl)-pyrimidin-5 -carbonsäure- N-methyl-N-(3-trifluormethyl-phenyl)- amid, Verfahren zu ihrer Herstellung, ihre Verwendung als Arzneimittel und Ausgangsprodukte

Legal Events

Date Code Title Description
PV Patent disclaimer (addendum to changes before extension act)